 Home > Active Ingredient News > Blood System > Leukemia: Preclinical evaluation of eltrombopag in the PDX model of myelodysplastic syndrome

Leukemia: Preclinical evaluation of eltrombopag in the PDX model of myelodysplastic syndrome

 Last Update: 2021-08-01
 Source: Internet
 Author: User

Tags

parkinson's disease treatment

femur bone marrow

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease characterized by bone marrow (BM) dysplasia, reduction of blood cells, recurrent genomic aberrations, and the susceptibility of the disease to develop into acute myeloid leukemia

Although the current research on the molecular characterization of MDS has made great progress, the lack of preclinical models to solve functional problems has also made it difficult to convert the discovered mutation data into new treatment strategies

In this study, the researchers mainly analyzed the effectiveness and safety of the thrombopoietin receptor agonist eltrombopag (Eltrombopag)

Researchers mainly analyzed the effectiveness and safety of the thrombopoietin receptor agonist eltrombopag

Preclinical evaluation using xenograft models derived from MDS patients

All in all, the results of the study reveal that the MDS PDX model can be used as a potential tool for testing new treatment concepts in MDS preclinical trials

The MDS PDX model can be used as a potential tool for testing new treatment concepts in MDS preclinical trials

Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.